Comparison between Manual and Automated Methods for Ki-67 Immunoexpression Quantification in Ameloblastomas
暂无分享,去创建一个
Ramón G Carreón-Burciaga | R. Gónzalez-Gónzalez | N. Molina-Frechero | R. Bologna-Molina | Rogelio González-González | Nelly Molina-Frechero | Sandra López-Verdín | Carlos Robles-Bonilla | Vanesa Pereira-Prado | Ronell Bologna-Molina | V. Pereira-Prado | Sandra López-Verdín | Carlos Robles-Bonilla
[1] Johannes Gerdes,et al. The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.
[2] R. Gónzalez-Gónzalez,et al. Immunohistochemical Expression of Survivin and Its Relationship with Cell Apoptosis and Proliferation in Ameloblastomas , 2015, Disease markers.
[3] K. R. Rao,et al. A comparison of manual and automated methods of quantitation of oestrogen/progesterone receptor expression in breast carcinoma. , 2015, Journal of clinical and diagnostic research : JCDR.
[4] Ali Bijani,et al. A comparative study of PCNA and Ki-67 expression in dental follicle, dentigerous cyst, unicystic ameloblastoma and ameloblastoma , 2013, International journal of molecular and cellular medicine.
[5] H. Coleman,et al. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[6] D. Perez,et al. Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas. , 2010, International journal of oral and maxillofacial surgery.
[7] M. Irigoyen-Camacho,et al. Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. , 2008, Oral oncology.
[8] R. Mesquita,et al. Odontogenic tumors: a study of 340 cases in a Brazilian population. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[9] Vilppu J. Tuominen,et al. Grading of Neuroendocrine Tumors With Ki-67 Requires High-quality Assessment Practices , 2012, The American journal of surgical pathology.
[10] G. Ramos,et al. Odontogenic tumors: a 14-year retrospective study in Santa Catarina, Brazil. , 2014, Brazilian oral research.
[11] N. Molina-Frechero,et al. An easy cell counting method for immunohistochemistry that does not use an image analysis program , 2011, Histopathology.
[12] R. Metgud,et al. Expression of cell cycle and apoptosis-related proteins in ameloblastoma and keratocystic odontogenic tumor. , 2013, Annals of diagnostic pathology.
[13] A. Stepan,et al. The evaluation of p16 and Ki67 immunoexpression in ameloblastomas. , 2014, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[14] M. Amin,et al. EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence , 2012, Diagnostic Pathology.
[15] Johannes Gerdes,et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.
[16] Ramón G Carreón-Burciaga,et al. Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns , 2015, Disease markers.
[17] Vilppu J Tuominen,et al. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 , 2010, Breast Cancer Research.